Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland

NCT04823182 is registered in ClinicalTrials.gov with Cardiovascular Research Institute Dublin as lead sponsor.

NCT NCT04823182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04823182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland
Lead sponsor
Cardiovascular Research Institute Dublin
Phase
Observational
Overall status
Unknown status
Start date
February 16, 2021
Completion date
September 22, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathies, covid19, sars-cov infection